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The MedAustron Ion therapy center will be constructed in Wiener Neustadt (Austria) in the 
vicinity of Vienna. Its accelerator complex consists of four ion sources, a linear accelerator, a 
synchrotron and a beam delivery system to the three medical treatment rooms and to the 
research irradiation room. 
The ion sources shall deliver beams of H31+, C4+ and light ions with utmost reliability and 
stability.  
This paper describes the features of the ion sources presently planned for the MedAustron 
facility; such as ion source main parameters, gas injection, temperature control and cooling 
systems. A dedicated beam diagnostics technique is proposed in order to characterize ECR 
ions beams; in the first drift region after the ion source, a fraction of the mixed beam is 
selected via moveable aperture. With standard beam diagnostics, we then aim to produce 
position-dependant observables such as ion-current density, beam energy distribution and 
emittance for each charge states to be compared to simulations of ECR e-heating, plasma 
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The MedAustron Ion therapy center will be constructed in Wiener Neustadt (Austria) in the vicinity of 
Vienna. Its accelerator complex consists of four ion sources, a linear accelerator, a synchrotron and a beam 
delivery system to the three medical treatment rooms and to the research irradiation room. 
The ion sources shall deliver beams of H31+, C4+ and light ions with utmost reliability and stability.  
This paper describes the features of the ion sources presently planned for the MedAustron facility; such as ion 
source main parameters, gas injection, temperature control and cooling systems. A dedicated beam 
diagnostics technique is proposed in order to characterize ECR ions beams; in the first drift region after the 
ion source, a fraction of the mixed beam is selected via moveable aperture. With standard beam diagnostics, 
we then aim to produce position-dependant observables such as ion-current density, beam energy distribution 
and emittance for each charge states to be compared to simulations of ECR e-heating, plasma simulation, 
beam formation and transport. 
 
I. INTRODUCTION 
The MedAustron1 ion-therapy facility is scheduled for first beam 
in 2013 and test operation will start in 2014. MedAustron is 
based on the PIMMS study2 and has a collaboration agreement 
with the National Centre of Oncological Hadrontherapy 
(CNAO)3 in Pavia and CERN. It will be equipped with three 
patient irradiation rooms. The first treatment room, equipped with 
a horizontal irradiation port, and the second with horizontal and 
vertical irradiation ports will be operating carbon ions and 
protons. The third treatment room will be equipped with a proton 
gantry. An additional irradiation room will be dedicated to 
research with light ions from protons to oxygen. The main 
components of the accelerator complex delivering these beams 
are four ion sources delivering beams of H31+, C4+ and light ions, 
a beam chopper, a linear accelerator composed of a Radio-
Frequency Quadrupole (RFQ) followed by IH drift tube linac 
(IH-DTL) accelerating structures at the end of which stripping of 
the H31+ to 3 protons and of C4+ to C6+ will take place prior to 
injection into the synchrotron.  The main parameters of the 
accelerator for medical treatment are presented in table 1 and The 
low energy beam transport section of the injector is presented in 
FIGURE 1. 
TABLE I. The MedAustron accelerator; Main parameters for 
medical treatment. 
Ions  Protons C6+  
Beam energy 60 to 250 MeV/u 120 to 400 MeV/u 
Pulse intensity 2×1010 ions 1×109 ions 
Extraction time 1.1 to 1 s (max 10 s) 
Repetition rate 0.5 Hz (max 1 Hz) 
In order to meet MedAustron’s ambitious goal of 1200 patients 
per year, highest availability of all elements of the accelerator 
chain is mandatory. In this paper, the main features of the four 
ion sources of the MedAustron facility are described and ways 









FIG. 1. Layout of MedAustron’s ion sources and low energy 
beam transport. Beam elements (color codes) starting from the 
ion source: solenoid (magenta), steerer (grey), diagnostics 
(brown), quadrupoles (red) and dipole magnets (green). The 
beam chopper and specific beam diagnostics are indicated. 
II. MedAustron ION SOURCES 
The operation schedule of MedAustron will evolve with 
time and should be independent from installed hardware; in this 
respect, specialization of the ion sources to ensure simultaneous 
availability of the C4+ (IS-1) and H31+ (IS-2) beams is proposed. 
A spare carbon or hydrogen molecular ion-beam (IS-Spare) will 
be available in the event of an ion source failure. Light ions 
beams will be relying on a single ion source (IS-R&D). All ion 
sources will be operating in parallel according to patient 
irradiation requirement during day time and to the R&D program 
over night and Sundays. The accelerator shut-down has to be as 
short as achievable; by making use of the ion source redundancy, 
some  of the yearly maintenance of the four ion sources could be 
done during standard operation provided that access is granted 
into the low energy room for extended period. Furthermore, it is 
likely that regular access will be necessary for short interventions 
and adapting the R&D ion source to new light ion-species. The 
low duty factor of the injection into the synchrotron allows 
pulsed operation of the ion source that could improve its mean 
time between maintenance and proportionally reduce ECR’s X-
rays emission. However, precise beam diagnostics and ion source 
tuning are more efficient using cw beams.  




Emittance (95%) 180 mm mrad 
IS-HT, energy spread 30 kV, < 1% 
24h Beam Stability  (peak to peak)          :   
Intensity and Emittance   
 
< 4% 
Reproducibility of all beam parameters 
after restart before tuning 
5% 
Maintenance  interval  
Duration (1 ion source) 
> 12 month 
< 2 weeks 
Synchrotron injection  < 100 s 
TABLE I. Main ion source parameters for medical application. 
A. H3
+ Ion source 
Molecular hydrogen ECR ion sources that are successfully used 
at HIMAC (H2+), CNAO (H3+) and HIT have appropriate ion 
current and emittances for MedAustron (500 A, 180 mm 
mrad). A filament volume ion source operated at IAP as proton 
linac injector could be considered provided that long term 
stability is demonstrated.    
B. Carbon Ion source 
ECR ion sources are successfully used at HIMAC, CNAO and 
HIT, a common feature of CH4 or CO2 is the deposition of thin 
carbon layers that is correlated with a slow evolution of the beam 
intensity. It must be underlined that MedAustorn’s emittance 
requirement (180 mm mrad) is challenging for most available 
ECR ion sources. Pulsed operation of the ion sources requires 
dedicated timing that must be optimized, the time constant for 
thermal stabilization in pulsed or cw mode will be measured. 
C. Light ions Ion source 
Light ion beams in the range between 50 and  250 A within an 
emittance of 180 mm mrad will be dedicated to research 
activities. For the production of light ions with charge to mass 
ratios higher than 1/3, ECR and Electron Beam ion sources 
(EBIS) are considered. The gaseous Hydrogen, Helium, 
Nitrogen, Oxygen and Neon can be directly injected into the ion-
sources. For Lithium, Beryllium, Boron and Carbon; vapors, 
volatile compounds or single charge state injection techniques are 
required. The choice of an EBIS implies the use of specific beam 
diagnostics and a pulse duration of the order of 100 s to match 
the multi-turn injection into the synchrotron. 
D. Temperature control 
Ion sources are often located in a rarely visited cellar and 
benefiting from air conditioning; these stable temperature 
conditions are one of the keys to the stability of the ion source. In 
the MedAustron low energy room, frequent accesses are expected 
and may influence the stability of the gas injection or ion-source 
temperature. The effect temperature on gas injection and 
therefore on the beam stability shall be minimized. Furthermore, 
the source must deliver the same beam parameters while 
restarting at nominal settings after a stop; this is the figure of 
merit of the ion source’s reliability. MedAustron’s gas injection 
relies on a precisely temperature controlled leakage valve (piezo 
for fast response or thermo-mechanic), its temperature and 
pressure will be monitored in order to regulate the density of the 
injected gas.4  
The body of the ion source, the RF injection wave guide and the 






FIG. 2. ECR ion source cooling systems of the RF injection wave 
guide, the body of the ion source and the ion extraction. 
E. Modeling and Beam diagnostics 
The ECR ion sources resonance region is defined by multipole 
and coils magnetic configuration. The ions produced in these 
regions will follow preferentially the field lines and contribute to 
the complexity of the observed beam profiles5. Simulation tools 
exist for electron heating (TrapCad6) plasma dynamics (Vorpal7) 
ion-extraction and beam formation (KOBRA8, IGUN9).  
 
FIG. 3. Electron loss Profile from an ECR ion source (hexapole 
magnetic configuration) as simulated with TrapCad. 
We propose to implement a moveable aperture (FIG. 4) located 
in a beam drift region after the first solenoid (FIG. 5) that allows 
selecting a fraction of the mixed elements and charge states 
passing through a diamond or square surface. A mobile faraday 
cup will be located behind the aperture system to integrate the 
transmitted beam. Using standard beam diagnostics in the 
magnet’s focal plane, the charge state distribution, emittance and 
integrated current are accessible for each beamlet. In order to 
measure the beam energy distribution, a decelerating device 
coupled to a faraday cup is located in the focal plane of the 
magnet. This system was used at Jyväskylä10 and ISOLDE11 and 
provides complementary information to the ion beam’s phase 
space. 
 
FIG. 4. Selection of a fraction of the beam via four plates. The 
size and position of the diamond or square aperture is tunable. 
 
FIG. 5. Ion-beam envelope at nominal beam optics settings. 
Modeling and ion-beam phase space measurements should be 
done before the commissioning of the accelerator; they are time 
consuming and would hugely benefit from a dedicated test 
period.  
E. Mechanics and alignment 
The redundancy of the ion sources for medical application (spare 
unit) may allow some time for the maintenance. However, the 
intervention time shall be minimized via specific design of the 
ion-source design in matter of assembly, maintenance and 
alignment. For the final alignment, a three feet structure is 
expected. The vibration induced by mechanical pumps has to be 
damped. 
III. CONCLUSION AND OUTLOOK 
Ion sources were identified that match most of the presently 
planned beam requirement of the MedAustron facility. Rooms for 
improvement were identified concerning mean time between 
failure, operation stability and maintenance that are crucial for 
medical applications. Simulations of plasma heating, ion-
transport within the ion source, ion extraction and beam transport 
are mandatory to fully grasp the complexity of the ion-injection. 
Specific beam instrumentation is proposed to validate the 
simulation results. These dedicated measurements would be an 
optimum training for MedAustron’s technical staff. Stabilization 
techniques are proposed for MedAustron ion sources, their 
commissioning could be achieved prior to the final installation at 
Wiener Neustadt provided that a test stand is assembled at 
CERN. 
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